CHONDROPROTECTIVE EFFECTS OF IL-6 INHIBITION THROUGH BLOCKADE OF THE STAT3 PATHWAY

被引：0
|
作者：
Latourte, A. [1 ,2 ]
Cherifi, C. [1 ,2 ]
Ea, H. -K. [1 ,2 ,3 ]
Bouaziz, W. [1 ,2 ]
Funck-Brentano, T. [1 ,2 ,3 ]
Solal, M. Cohen [1 ,2 ,3 ]
Hay, E. [1 ,2 ]
Richette, P. [1 ,2 ,3 ]
机构：
[1] Ctr Viggo Petersen, INSERM, U1132, Paris, France
[2] Univ Paris Diderot Paris 7, Paris, France
[3] Hop Lariboisiere, Ctr Viggo Petersen, Federat Rhumatol, Paris, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.2067
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0035
引用
收藏
页码：661 / 661
页数：1
相关论文
共 50 条
  • [1] Hepatoprotection via the IL-6/Stat3 pathway
    Taub, R
    JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (07): : 978 - 980
  • [2] Nicotine suppresses the development of colitis-associated cancer through the inhibition of IL-6/Stat3 pathway in mice
    Hayashi, Shusaku
    Hamada, Takayuki
    Ishii, Yoko
    Sasahara, Masakiyo
    Kadowaki, Makoto
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 : 229P - 229P
  • [3] Nicotine Suppresses Colonic Tumorigenesis Associated With Chronic Colitis Through the Inhibition of IL-6/STAT3 Pathway in Mice
    Hayashi, Shusaku
    Hamada, Takayuki
    Ishii, Yoko
    Sasahara, Masakiyo
    Kadowaki, Makoto
    GASTROENTEROLOGY, 2014, 146 (05) : S631 - S631
  • [4] Inhibition of Sphingolipid Pathway Affects Cholesterol Gallstone Formation in Mice by the Modulation of IL-6/STAT3 Pathway
    Lim, Eun-Hye
    Kim, Jae Seon
    Lee, Beom Jae
    Jeong, Yoon A.
    Park, Jong-Jae
    Lee, Joon Young
    Jung, Wonho
    Lim, Sang-ah
    Lee, Sehe Dong
    Bak, Young-Tae
    GASTROENTEROLOGY, 2012, 142 (05) : S606 - S606
  • [5] Progress in Understanding the IL-6/STAT3 Pathway in Colorectal Cancer
    Lin, Yan
    He, Ziqin
    Ye, Jiazhou
    Liu, Ziyu
    She, Xiaomin
    Gao, Xing
    Liang, Rong
    ONCOTARGETS AND THERAPY, 2020, 13 : 13023 - 13032
  • [6] TREATMENT WITH IL-6 BLOCKADE IN PATIENTS WITH GAIN OF FUNCTION STAT3 MUTATIONS
    Castro-Wagner, Johana B.
    Kumar, Ashish R.
    Jolley, Christopher
    Vogel, Tiphanie P.
    Cooper, Megan A.
    Leiding, Jennifer W.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2016, 36 (03) : 314 - 314
  • [7] Trilobolide-6-O-isobutyrate suppresses hepatocellular carcinoma tumorigenesis through inhibition of IL-6/STAT3 signaling pathway
    Zhou, Xiu-Qiao
    Mao, Xiao-Mei
    Fan, Rui
    Li, Si-Yang
    Shang, Jin
    Zhang, Tong
    Li, Rui-Han
    Li, Hui-Qi
    Hui, Yang
    Chen, Wen-Hao
    Wang, Zhan-Xiang
    Shen, Dong-Yan
    PHYTOTHERAPY RESEARCH, 2021, 35 (10) : 5741 - 5753
  • [8] Micheliolide inhibits gastric cancer growth in vitro and in vivo via blockade of the IL-6/STAT3 pathway
    Tang, Xiaogang
    Ding, Qiulong
    Chen, Chao
    Chen, Fei
    Zhou, Xiyang
    Hong, ChuJie
    Pan, Wensheng
    PHARMAZIE, 2019, 74 (03): : 175 - 178
  • [9] Inhibition of sphingolipid pathway affects the formation of cholesterol gallstone by the modulation of Il-6/Stat3 pathway in mice model
    Yun, Jae-Won
    Kim, Jae Seon
    Choi, Woo Seok
    Kim, Sung Ho
    Noh, Hyejin
    Lee, Beom Jae
    Park, Jong-Jae
    Bak, Young-Tae
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 85 - 86
  • [10] Genetic variants in IL-6/JAK/STAT3 pathway and the risk of CRC
    Wang, Shuwei
    Zhang, Weidong
    TUMOR BIOLOGY, 2016, 37 (05) : 6561 - 6569
12345